Human guinea pigs in a London lab are to be given a form of the killer virus as the search for a lucrative jab hots up Sunday March 08 2020,… read more →
Open Orphan plc (“Open Orphan” or the “Company”) Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO’s 49% joint… read more →
Mon, Mar 9, 2020, Company will deliberately expose humans to a coronavirus in bid for Covid-19 vaccine Open Orphan executive chairman Cathal Friel said the acquisition of Hvivo was reaping… read more →
Open Orphan, a Europe- focused pharma services company specialising in rare disease and so-called orphan drugs, has agreed a contract with a European biotech company that could generate up to… read more →
Fri, Mar 6, 2020, Dublin-listed pharma group announces contract with European biotech company Open Orphan executive chairman Cathal Friel said the acquisition of Hvivo was reaping benefits for the company.… read more →